Regeneron to Report First Quarter 2014 Financial and Operating Results and Host Conference Call and Webcast on May 8, 2014

  Regeneron to Report First Quarter 2014 Financial and Operating Results and                Host Conference Call and Webcast on May 8, 2014  PR Newswire  TARRYTOWN, N.Y., April 11, 2014  TARRYTOWN, N.Y., April 11, 2014 /PRNewswire/ --Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN)  today announced that it will report its first quarter 2014 financial and operating results on Thursday, May 8, 2014, before the U.S. financial markets open. The Company will host a conference call and simultaneous webcast at 8:30 AM Eastern Time that day.  Conference Call Information To access this call, dial (888) 660-6127 (U.S.) or (973) 890-8355 (International). A link to the webcast may be accessed from the 'Events and Presentations' page of Regeneron's website at www.regeneron.com. A replay of the conference call and webcast will be archived on the Company's website and will be available for 30 days.  About Regeneron Pharmaceuticals, Inc. Regeneron is a leading science-based biopharmaceutical company based in Tarrytown, New York that discovers, invents, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions. Regeneron markets medicines for eye diseases, colorectal cancer, and a rare inflammatory condition and has product candidates in development in other areas of high unmet medical need, including hypercholesterolemia, oncology, rheumatoid arthritis, asthma and atopic dermatitis. For additional information about the company, please visit www.regeneron.com.  Contact Information: Manisha Narasimhan, Ph.D.         Peter Dworkin Investor Relations               Corporate                                   Communications 914-847-5126                     914-847-7640  manisha.narasimhan@regeneron.com peter.dworkin@regeneron.com    SOURCE Regeneron Pharmaceuticals, Inc.  Website: http://www.regeneron.com  
Press spacebar to pause and continue. Press esc to stop.